Research & Development

23-Year Study Confirms PSA Screening Cuts Prostate Cancer Deaths
Research & Development 23-Year Study Confirms PSA Screening Cuts Prostate Cancer Deaths

Every year, countless men face a silent threat that often goes undetected until it’s too late—prostate cancer, which stands as one of the leading causes of cancer-related deaths among men globally. This disease claims lives with a stealth that makes early detection both a challenge and a necessity.

How Is eConsent Transforming Clinical Trials Digitally?
Research & Development How Is eConsent Transforming Clinical Trials Digitally?

The landscape of clinical trials is undergoing a seismic shift as digital innovations reshape every aspect of research, with electronic consent (eConsent) emerging as a pivotal force in this transformation, especially as trials adopt decentralized and hybrid frameworks to accommodate diverse and

Jupiter Lab Targets HIV Cure with Innovative Drug Research
Research & Development Jupiter Lab Targets HIV Cure with Innovative Drug Research

In a world where HIV continues to impact millions globally, a groundbreaking effort at The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology in Jupiter, Florida, is sparking hope for a transformative solution. This research hub has embarked on an ambitious journey to

Can Global Cell Therapy Networks Transform Cancer Care?
Research & Development Can Global Cell Therapy Networks Transform Cancer Care?

In the relentless battle against cancer, groundbreaking treatments such as cell therapies have emerged as beacons of hope, offering personalized solutions that can target the disease with unprecedented precision. However, for countless patients across the globe, particularly in regions with limited

Aspirin Cuts Cancer Recurrence Risk by 55% in Genetic Study
Research & Development Aspirin Cuts Cancer Recurrence Risk by 55% in Genetic Study

In a world where colorectal cancer continues to affect nearly two million people annually, a groundbreaking discovery offers a glimmer of hope for those battling this devastating disease, and a recent clinical trial conducted by a Swedish research team has unveiled a remarkable finding. A simple,

Can Encaleret Revolutionize Rare Disease Treatment?
Research & Development Can Encaleret Revolutionize Rare Disease Treatment?

In a landscape where rare diseases often linger in the shadows of medical research, autosomal dominant hypocalcemia Type 1 (AD#), a condition affecting calcium regulation, impacts thousands with limited treatment options. With an estimated 12,000 individuals in the U.S. grappling with this

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later